NCT02315677

Brief Summary

The purpose of this study is to determine the degree of epistaxis following nasal intubation with either a nasal endotracheal (RAE) tube with bevel facing left or Parker Flex-Tip endotracheal tube with bevel facing posteriorly The investigators hypothesize that a Parker Flex-Tip endotracheal tube when inserted with bevel facing posteriorly during nasal intubation may reduce the incidence of epistaxis intra and post-operatively. The investigators propose that using this style of endotracheal tube improves patient safety and comfort and facilitates ease and success of nasal intubation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2014

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 12, 2014

Completed
20 days until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

January 8, 2016

Status Verified

January 1, 2016

Enrollment Period

10 months

First QC Date

November 24, 2014

Last Update Submit

January 6, 2016

Conditions

Keywords

EpistaxisNasal IntubationMaxillofacial surgery

Outcome Measures

Primary Outcomes (2)

  • Reduced Epistaxis

    The degree of epistaxis will be assessed by a blinded independent investigator immediately post intubation, and along with ease of insertion, recorded. Quantity of epistaxis will be measured by swabbing the nasopharynx with a dry swab and measuring the difference in weight gain between the dry swab and blood soaked swab. Epistaxis will be evaluated based on the criteria established by Sugiyama et al. Four grades will be used: 1. No epistaxis, no blood observed on either the surface of the tube or the posterior pharyngeal wall 2. Mild epistaxis with blood apparent on the surface of the tube or posterior pharyngeal wall 3. Moderate epistaxis with pooling of blood on the posterior pharyngeal wall 4. Severe epistaxis with a large amount of blood in the pharynx impeding nasotracheal intubation and necessitating urgent orotracheal intubation

    Immediately post intubation

  • Reduced Epistaxis

    The degree of epistaxis will be assessed by a blinded independent investigator 5 minutes post intubation, and along with ease of insertion, recorded. Quantity of epistaxis will be measured by swabbing the nasopharynx with a dry swab and measuring the difference in weight gain between the dry swab and blood soaked swab. Epistaxis will be evaluated based on the criteria established by Sugiyama et al. Four grades will be used: 1. No epistaxis, no blood observed on either the surface of the tube or the posterior pharyngeal wall 2. Mild epistaxis with blood apparent on the surface of the tube or posterior pharyngeal wall 3. Moderate epistaxis with pooling of blood on the posterior pharyngeal wall 4. Severe epistaxis with a large amount of blood in the pharynx impeding nasotracheal intubation and necessitating urgent orotracheal intubation

    5 minutes post intubation

Secondary Outcomes (3)

  • Ease of tube insertion

    Immediately post intubation

  • Number of attempts to insert tube

    Immediately post intubation

  • Post-operative patient nasal pain

    Within 2 hours after extubation

Study Arms (2)

Nasal intubation-Standard RAE ETT

ACTIVE COMPARATOR

This arm will receive nasal intubation with the standard RAE endotracheal tube with bevel facing left.

Device: Nasal Intubation with nasal RAE endotracheal tubeDevice: Nasal Intubation with Parker Flex-Tip endotracheal tube

Nasal intubation-Parker Flex-Tip ETT

ACTIVE COMPARATOR

This arm will receive nasal intubation with the Parker Flex-tip ETT with bevel facing posteriorly.

Device: Nasal Intubation with nasal RAE endotracheal tubeDevice: Nasal Intubation with Parker Flex-Tip endotracheal tube

Interventions

A single experienced operator with at least 5 years of clinical anesthetic experience will intubate using the standard nasal RAE endotracheal tube with bevel facing leftward.

Nasal intubation-Parker Flex-Tip ETTNasal intubation-Standard RAE ETT

A single experienced operator with at least 5 years of clinical anesthetic experience will intubate using the Parker Flex-Tip endotracheal tube with the bevel facing posteriorly.

Nasal intubation-Parker Flex-Tip ETTNasal intubation-Standard RAE ETT

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female patients
  • Over 16 years of age. The investigators definitely do not want to recruit anyone under age 16 yr
  • Undergoing an oral or maxillofacial surgery where nasal intubation would be appropriate for surgical anesthesia
  • General anesthesia and nasal intubation discussed and planned in the preoperative assessment clinic
  • ASA physical status I or II patients undergoing oral or maxillofacial surgery where nasal intubation would be appropriate for surgical anesthesia.
  • ASA Physical Status 1 - A normal healthy patient ASA Physical Status 2 - A patient with mild systemic disease ASA Physical Status 3 - A patient with severe systemic disease ASA Physical Status 4 - A patient with severe systemic disease that is a constant threat to life ASA Physical Status 5 - A moribund patient who is not expected to survive without the operation

You may not qualify if:

  • Patients not clinically amenable to general anesthesia
  • Documented anatomical deformities in the region of interest which includes nasal passages, internal nasal turbinates and nasopharynx. These structures will henceforth be called"region of interest."
  • History of trauma in the region of interest
  • Previous surgery in the region of interest
  • Coagulation defects
  • Anticoagulant medication other than Low Dose Aspirin
  • History of recurrent epistaxis
  • Age less than 16 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of British Columbia Department of Anesthesiology, Pharmacology and Therapeutics

Vancouver, British Columbia, V6Z 1L8, Canada

Location

Related Publications (13)

  • Morimoto Y, Sugimura M, Hirose Y, Taki K, Niwa H. Nasotracheal intubation under curve-tipped suction catheter guidance reduces epistaxis. Can J Anaesth. 2006 Mar;53(3):295-8. doi: 10.1007/BF03022218.

    PMID: 16527796BACKGROUND
  • Chin KJ, Perlas A. Ultrasonography of the lumbar spine for neuraxial and lumbar plexus blocks. Curr Opin Anaesthesiol. 2011 Oct;24(5):567-72. doi: 10.1097/ACO.0b013e32834aa234.

    PMID: 21822134BACKGROUND
  • Hall CE, Shutt LE. Nasotracheal intubation for head and neck surgery. Anaesthesia. 2003 Mar;58(3):249-56. doi: 10.1046/j.1365-2044.2003.03034.x.

    PMID: 12603455BACKGROUND
  • Williams AR, Burt N, Warren T. Accidental middle turbinectomy: a complication of nasal intubation. Anesthesiology. 1999 Jun;90(6):1782-4. doi: 10.1097/00000542-199906000-00039. No abstract available.

    PMID: 10360881BACKGROUND
  • Dost P, Armbruster W. Nasal turbinate dislocation caused by nasotracheal intubation. Acta Anaesthesiol Scand. 1997 Jun;41(6):795-6. doi: 10.1111/j.1399-6576.1997.tb04787.x.

    PMID: 9241346BACKGROUND
  • Tintinalli JE, Claffey J. Complications of nasotracheal intubation. Ann Emerg Med. 1981 Mar;10(3):142-4. doi: 10.1016/s0196-0644(81)80379-4.

    PMID: 7469154BACKGROUND
  • Dinner M, Tjeuw M, Artusio JF Jr. Bacteremia as a complication of nasotracheal intubation. Anesth Analg. 1987 May;66(5):460-2. doi: 10.1213/00000539-198705000-00017. No abstract available.

    PMID: 3578854BACKGROUND
  • O'Connell JE, Stevenson DS, Stokes MA. Pathological changes associated with short-term nasal intubation. Anaesthesia. 1996 Apr;51(4):347-50. doi: 10.1111/j.1365-2044.1996.tb07746.x.

    PMID: 8686823BACKGROUND
  • Sugiyama K, Manabe Y, Kohjitani A. A styletted tracheal tube with a posterior-facing bevel reduces epistaxis during nasal intubation: a randomized trial. Can J Anaesth. 2014 May;61(5):417-22. doi: 10.1007/s12630-014-0156-3. Epub 2014 Mar 28.

    PMID: 24740408BACKGROUND
  • Seo KS, Kim JH, Yang SM, Kim HJ, Bahk JH, Yum KW. A new technique to reduce epistaxis and enhance navigability during nasotracheal intubation. Anesth Analg. 2007 Nov;105(5):1420-4, table of contents. doi: 10.1213/01.ane.0000281156.64133.bd.

    PMID: 17959976BACKGROUND
  • Watt S, Pickhardt D, Lerman J, Armstrong J, Creighton PR, Feldman L. Telescoping tracheal tubes into catheters minimizes epistaxis during nasotracheal intubation in children. Anesthesiology. 2007 Feb;106(2):238-42. doi: 10.1097/00000542-200702000-00010.

    PMID: 17264716BACKGROUND
  • Kim YC, Lee SH, Noh GJ, Cho SY, Yeom JH, Shin WJ, Lee DH, Ryu JS, Park YS, Cha KJ, Lee SC. Thermosoftening treatment of the nasotracheal tube before intubation can reduce epistaxis and nasal damage. Anesth Analg. 2000 Sep;91(3):698-701. doi: 10.1097/00000539-200009000-00038.

    PMID: 10960403BACKGROUND
  • Earle R, Shanahan E, Vaghadia H, Sawka A, Tang R. Epistaxis during nasotracheal intubation: a randomized trial of the Parker Flex-Tip nasal endotracheal tube with a posterior facing bevel versus a standard nasal RAE endotracheal tube. Can J Anaesth. 2017 Apr;64(4):370-375. doi: 10.1007/s12630-017-0813-4. Epub 2017 Jan 11.

MeSH Terms

Conditions

Epistaxis

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Himat Vaghadia, MBBS

    Vancouver Coastal Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2014

First Posted

December 12, 2014

Study Start

January 1, 2015

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

January 8, 2016

Record last verified: 2016-01

Locations